Yoshifumi Morikawa

Lambertellols A and B, Novel 3,4-Dihydronaphthalen-1(2<i>H</i>)-ones with Spiro-butenolide Produced by <i>Lambertella </i>sp.1346

Takanori Murakami, Yoshifumi Morikawa, Masaru Hashimoto et al. · Organic Letters · 2003 · 60 citations

Diversity Oriented Synthesis, Bioorganic Chemistry, Engineering +14

Acquisition of doxorubicin resistance facilitates migrating and invasive potentials of gastric cancer MKN45 cells through up-regulating aldo–keto reductase 1B10

Yoshifumi Morikawa, Chihiro Kezuka, Satoshi Endo et al. · Chemico-Biological Interactions · 2015 · 45 citations

Tumor Biology, Oncology, Doxorubicin Resistance +11

Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells

Satoshi Endo, Shuang Xia, Miho Suyama et al. · Journal of Medicinal Chemistry · 2017 · 43 citations · Full text

Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells

Toshiyuki Matsunaga, Ayano Yamaguchi, Yoshifumi Morikawa et al. · Anti-Cancer Drugs · 2014 · 36 citations

Aldo-keto Reductase, Chemoprevention Strategy, Cell Differentiation +18

α-Pyrrolidinononanophenone provokes apoptosis of neuronal cells through alterations in antioxidant properties

Toshiyuki Matsunaga, Yoshifumi Morikawa, Kyohei Kamata et al. · Toxicology · 2017 · 36 citations

Biochemistry, Medicine, Apoptosis +11